Certified by Founder Lodge
Epigenic Therapeutics
China - Shanghai
START UP
1 Disclosed Funding Rounds $32,000,000
0 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Epigenic Therapeutics is a frontier biotechnology company dedicated to developing next generation gene editing therapy utilizing regulation of epigenetic genome for a variety of diseases. Fou
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| August, 30 ,2023 | Series A | $32,000,000 | |
| September, 09 ,2025 | Series B | $60,000,000.00 |
OrbiMed
Qiming Venture Partners
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Honey Health | $7,800,000 | (Oct 28, 2025)
Serval | $47,000,000 | (Oct 28, 2025)
SavvyMoney | $225,000,000 | (Oct 28, 2025)
PodPlay Technologies | $8,000,000 | (Oct 28, 2025)
Natural | $9,800,000 | (Oct 28, 2025)
